Related Experiment Video
Updated: Mar 30, 2026

Bioluminescence Imaging of NADPH Oxidase Activity in Different Animal Models
Published on: October 22, 2012
NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient
Heike Langbein1, Coy Brunssen1, Anja Hofmann1
1Division of Vascular Endothelium and Microcirculation, Department of Medicine III, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Fetscherstr. 74, 01307 Dresden, Germany.
Aims:
Endothelial dysfunction is an early step in the development of atherosclerosis. Increased formation of superoxide anions by NADPH oxidase Nox1, 2, and 5 reduces nitric oxide availability and can promote endothelial dysfunction. In contrast, recent evidence supports a vasoprotective role of H2O2 produced by main endothelial isoform Nox4. Therefore, we analysed the impact of genetic deletion of Nox4 on endothelial dysfunction and atherosclerosis in the low-density lipoprotein receptor (Ldlr) knockout model.
Methods And Results:
Ex vivo analysis of endothelial function by Mulvany myograph showed impaired endothelial function in thoracic aorta of Nox4(-/-)/Ldlr(-/-) mice. Further progression of endothelial dysfunction due to high-fat diet increased atherosclerotic plaque burden and galectin-3 staining in Nox4(-/-)/Ldlr(-/-) mice compared with Ldlr(-/-) mice. Under physiological conditions, loss of Nox4 does not influence aortic vascular function. In this setting, loss of Nox4-derived H2O2 production could be partially compensated for by nNOS upregulation. Using an innovative optical coherence tomography approach, we were able to analyse endothelial function by flow-mediated vasodilation in the murine saphenous artery in vivo. This new approach revealed an altered flow-mediated dilation in Nox4(-/-) mice, indicating a role for Nox4 under physiological conditions in peripheral arteries in vivo.
Conclusions:
Nox4 plays an important role in maintaining endothelial function under physiological and pathological conditions. Loss of Nox4-derived H2O2 could be partially compensated for by nNOS upregulation, but severe endothelial dysfunction is not reversible. This leads to increased atherosclerosis under atherosclerotic prone conditions.
Insights
Genetic deletion of Nox4 worsens endothelial dysfunction and atherosclerosis. Loss of Nox4-derived hydrogen peroxide (H2O2) leads to severe endothelial dysfunction and increased plaque burden in mice.
Area of Science:
- Cardiovascular Biology
- Oxidative Stress
- Atherosclerosis Research
Background:
- Endothelial dysfunction is a key early event in atherosclerosis development.
- NADPH oxidases (Nox) 1, 2, and 5 contribute to dysfunction by reducing nitric oxide.
- Nox4, the main endothelial isoform, produces hydrogen peroxide (H2O2) with a vasoprotective role.
Purpose of the Study:
- To investigate the impact of genetic Nox4 deletion on endothelial dysfunction.
- To assess the role of Nox4 in the development of atherosclerosis in a mouse model.
Main Methods:
- Utilized the low-density lipoprotein receptor (Ldlr) knockout mouse model.
- Assessed ex vivo endothelial function using Mulvany myography.
- Analyzed in vivo endothelial function via optical coherence tomography (OCT) for flow-mediated dilation.
Main Results:
- Nox4(-/-)/Ldlr(-/-) mice exhibited impaired endothelial function and increased atherosclerotic plaque burden compared to Ldlr(-/-) controls.
- High-fat diet exacerbated endothelial dysfunction and atherosclerosis in Nox4-deficient mice.
- In vivo analysis revealed altered flow-mediated dilation in Nox4(-/-) mice, highlighting Nox4's role in peripheral arteries.
Conclusions:
- Nox4 is crucial for maintaining endothelial function in both physiological and pathological states.
- While nNOS upregulation can partially compensate for H2O2 loss, severe endothelial dysfunction and accelerated atherosclerosis occur without Nox4.
- Genetic deletion of Nox4 significantly contributes to endothelial dysfunction and promotes atherosclerosis progression.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction

